Troubles fonctionnels intestinaux et impact en santé publique

Functional bowel disorders and their impact on Public Health

Résumé

Le syndrome de l’intestin irritable (SII) au sens strict touche environ 5 % de la population françise, mais prés de 70 % des sujets adultes se plaignent de symptômes digestifs fréquents. Le SII est á l’origine de coûts directs modérés (72 á 1 590 € par an et par patient), probablement sous-estimés, mais qui finissent par représenter une dépense de santé importante compte tenu de la fréquence de la maladie et de son caracte`re chronique et récurrent. Les coûts indirects sont mal connus et sans doute plus importants compte tenu du retentissement du SII sur la qualité de vie.

Abstract

Five percent of the French population suffer from true irritable bowel syndrome but almost 70% of adults complain of frequent digestive problems. IBS generates moderate direct costs per subject (72 to 1 590 € a year), which is more than likely an underestimate, but this is a significant health cost considering the frequency of the disease and its chronic and recurrent nature. Indirect costs are difficult to assess but are certainly significant considering the impact of irritable bowel syndrome on quality of life.

This is a preview of subscription content, access via your institution.

Références

  1. 1.

    Amouretti M, Le Pen C, Gaudin AF, et al. (2006) Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL). Gastroenterol Clin Biol; 30: 241–246

    PubMed  Google Scholar 

  2. 2.

    El-Serag HB, Olden K, Bjorkman D (2002) Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 16: 1171–1185

    PubMed  Article  CAS  Google Scholar 

  3. 3.

    Gralnek IM, Hays RD, Kilbourne A, et al. (2000) The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 119: 654–660

    PubMed  Article  CAS  Google Scholar 

  4. 4.

    Bommelaer G, Poynard T, Le Pen C, et al. (2004) Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria. Gastroenterol Clin Biol 28: 554–561

    PubMed  Google Scholar 

  5. 5.

    Dapoigny M, Bellanger J, Bonaz B, et al. (2004) Irritable bowel syndrome in France: a common, debilitating and costly disorder. Eur J Gastroenterol Hepatol 16: 995–1001

    PubMed  Article  Google Scholar 

  6. 6.

    Hungin AP, Whorwell PJ, Tack J, et al. (2003) The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 17: 643–650

    PubMed  Article  CAS  Google Scholar 

  7. 7.

    Frexinos J, Denis P, Allemand H, et al. (1998) É tude descriptive des symptômes fonctionnels digestifs au sein de la population françise. Gastroenterol Clin Biol 22: 785–791

    PubMed  CAS  Google Scholar 

  8. 8.

    Le Pen C, Ruszniewski P, Gaudin AF, et al. (2004) The burden cost of French patients suffering from irritable bowel syndrome. Scand J Gastroenterol 39: 336–343

    PubMed  Article  Google Scholar 

  9. 9.

    Bentkover JD, Field C, Geene E, et al. (1999) The economic burden of irritable bowel syndrome in Canada. Can J Gastroenterol 13Suppl A: 89A–96A

    PubMed  Google Scholar 

  10. 10.

    Creed F, Ratcliffe J, Fernandez L, et al. (2001) Healthrelated quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med 134,9 Pt 2: 860–868

    PubMed  CAS  Google Scholar 

  11. 11.

    Danchequin Dorval E, Delvaux M, et al. (1994) Profil et évolution du syndrome de l’intestin irritable: étude épidémiologique nationale prospective chez 1301 consultants en gastroentérologie suivis 9 mois. Gastroenterol Clin Biol 18: 145–150

    Google Scholar 

  12. 12.

    Dapoigny M, Dyard F, Grimaud JC, et al. (2003) Syndrome de l’intestin irritable et consommation de soins. Étude observationnelle en gastroentérologie. Gastroenterol Clin Biol 27: 265–271

    PubMed  Google Scholar 

  13. 13.

    Brun-Strang C, Dapoigny M, Lafuma A, et al. (2007) Irritable bowel syndrome in France: quality of life, medical management and costs: The ENCOLI study. Eur J Gastroenterol Hepatol

  14. 14.

    Coffin B, Dapoigny M, Cloarec D, et al. (2004) Relationship between severity of symptoms and quality of life in 858 patients with irritable bowel syndrome. Gastroenterol Clin Biol 28: 11–15

    PubMed  Article  Google Scholar 

  15. 15.

    Thompson WG, Longstreth GF, Drossman DA, et al. (1999) Functional bowel disorders and functional abdominal pain. Gut 45,Suppl 2: 43–47

    Google Scholar 

  16. 16.

    Longstreth GF, Thompson WG, Chey WD, et al. (2006) Functional bowel disorders. Gastroenterology 130: 1480–1491

    PubMed  Article  Google Scholar 

  17. 17.

    Hasler WL, Schoenfeld P (2003) Abdominal and pelvic surgery in patients with irritable bowel syndrome. Aliment Pharmacol Ther 17: 997–1005

    PubMed  Article  CAS  Google Scholar 

  18. 18.

    Francis CY, Duffy JN, Whorwell PJ, et al. (1996) Does routine abdominal ultrasound enhance diagnostic accuracy in irritable bowel syndrome? Am J Gastroenterol 91:1348–1350

    PubMed  CAS  Google Scholar 

  19. 19.

    Muller-Lissner SA, Pirk O (2002) Irritable bowel syndrome in Germany. A cost of illness study. Eur J Gastroenterol Hepatol 14,12: 1325–1329

    PubMed  Article  Google Scholar 

  20. 20.

    Cash B, Sullivan S, Barghout V (2005) Total costs of IBS: employer and managed care perspective. Am J Manag Care 11(1 Suppl): S7–16

    PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to M. Dapoigny.

About this article

Cite this article

Dapoigny, M. Troubles fonctionnels intestinaux et impact en santé publique. Colon Rectum 1, 255–258 (2007). https://doi.org/10.1007/s11725-007-0063-7

Download citation

Mots clés

  • Syndrome de l’intestin irritable
  • Qualité de vie
  • Coûts directs
  • Coûts indirects

Keywords

  • Irritable bowel syndrome
  • Quality of life
  • Direct costs
  • Indirect costs